Search This Blog

Wednesday, July 31, 2019

Vanda Pharmaceuticals EPS beats by $0.26, beats on revenue

Vanda Pharmaceuticals (NASDAQ:VNDA): Q2 Non-GAAP EPS of $0.28 beats by $0.26; GAAP EPS of $0.21 beats by $0.19.
Revenue of $59.06M (+24.7% Y/Y) beats by $4.87M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)